Review article: strategies for the management of chronic unremitting ulcerative colitis
Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease – insights into study design for transient lower sphincter relaxation inhibitors
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral
Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
Natural history of acute upper GI bleeding due to tumours: short-term success and long-term recurrence with or without endoscopic therapy
Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis
Young adults with coeliac disease may be at increased risk of early atherosclerosis
Functional dyspepsia: the economic impact to patients
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?
Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease
Commentary: revisiting the past – does it hold the key to the future treatment of refractory GERD?
Commentary: revisiting the past – does it hold the key to the future treatment of refractory GERD? Author's reply
Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy – optimisation is the way forward
Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy – optimisation is the way forward; authors' reply
Letter: mucosal healing in ulcerative colitis – higher relevance than in Crohn's disease?
Letter: mucosal healing in ulcerative colitis – higher relevance than in Crohn's disease? Authors' reply
Letter: lansoprazole consumption is more common in Japanese patients with collagenous colitis
Letter: lansoprazole consumption is more common in Japanese patients with collagenous colitis – authors’ reply
Corrigendum